A possible role for 15-lipoxygenase in atherogenesis

Trends in Cardiovascular Medicine

Volumn 5, Issue 1, 1995, Pages 29-36

  Harats, Dror ^a   Mulkins, Mary A ^a   Sigal, Elliott ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 5,8,11,14 ICOSATETRAYNOIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONATE 15 LIPOXYGENASE; BUTYLCRESOL; CELL ADHESION MOLECULE; CHEMOATTRACTANT; COPPER; CYTOKINE; EDETIC ACID; GROWTH FACTOR; IRON; LIPOXYGENASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; MYELOPEROXIDASE; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; NITRIC OXIDE SYNTHASE; PROBUCOL; PROSTAGLANDIN SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ATHEROGENESIS; ATHEROSCLEROSIS; CHEMOTAXIS; CYTOTOXICITY; ENZYME ACTIVITY; FOAM CELL; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0028930887     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/1050-1738(94)00029-U     Document Type: Short Survey

References (54)

1. The oxygenation of cholesterol esters by the reticulocyte lipoxygenase
2. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium
3. Selective conversion and esterification of monohydroxyeicosatetraenoic acids by human vascular smooth muscle cells: relevance to smooth muscle cell proliferation
4. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroslerosis in Watanabe heritable hyperlipidemic rabbit
5. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase
6. Interleukin 4 upregulates ω-6 lipoxygenase and scavenger receptors in human and mouse macrophages
7. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
8. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbit
9. The effect of probucol on the progression of atherosclerosis in mature Watanabe heritable hypercholesterolemic rabbits
10. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
11. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
12. Malondialdehyde alteration of low-density liporrotein leads to cholesterol accumulation in human monocyte-macrophages
13. Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation
14. Arachidonate 15-lipoxygenase: characteristics and potential biological significance
15. Coronary sinus sampling of cytokines after heart transplantation evidence for macrophage activation and interleukin-4 production within the graft
16. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition
17. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hypercholesterolemic rabbits
18. Detection of activated T lymphocytes in the human atherosclerotic plaque
19. Immunohistochemical detection of macrophages and T lymphocytes in atheroscerotic lesions of cholesterol-fed rabbits
20. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages
21. The role of sulfur-containing amino acids in superoxide production and modification of low-density lipoprotein by arterial smooth muscle cells
22. Formation of 15-HETE as a major hydroxyeicosatetranoic acid in the atherosclerotic vessel wall
23. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
24. 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low density lipoprotein
25. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoprotein
26. Oxygenation of biological membranes by the pure reticulocyte lipoxygenase
27. Overexpression purification and characterization of human recombinant 15-lipoxygenase
28. Involvement of 15-lipoxygenase in early stages of atherogenesis
29. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo
30. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leucocyte adhesion molecule, in rabbit aortic endothelum
31. Activated human monocytes oxidize low density lipoprotein by a lipoxygenase-dependent pathway
32. Rabbit reticulocyte lipoxygenase catalyses specific 12(s) and 15(s) oxygenation of arachidononylphosphatidyl choline
33. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein
34. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins
35. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages
36. Expression of 15-lipoxygenase in transplant coronary artery disease
37. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells
38. Molecular cloning and primary structure of human 15-lipoxygenase
39. Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related
40. Oxidation, lipoxygenase, and atherosclerosis
41. Formation of 15-hydroxyeicosatetraeonic acid (15-HETE) as the predominant eicosanoid in aorta from Watanabe heritable hyperlipidemic and cholesterol-fed rabbits
42. Relationship of vascular 15-lipoxygenase induction to atherosclerotic plaque formation in rabbits
43. Cellular oxidative modification of low density lipoprotein does not require lipoxygenase
44. 2 mimics cell-mediated oxidative modification
45. Vitamin E consumption and the risk of coronary disease in women
46. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels
47. Modified forms of low-density lipoprotein and atherosclerosis
48. Beyond cholesterol. Modification of low-density lipoprotein that increase its atherogenicity
49. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
50. Polyclonal origin of T lymphocytes in human atherosclerotic plaques
51. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
52. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis
53. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions
54. Gene expression in macrophage-rich human atherosclerotic lesion